SCHEMBL18599259

SCHEMBL18599259

C=CCC(N/C=C\CN)c1cccc(C#N)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.37
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPT P10636 1/20 0.34
ALOX15 P16050 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ADRA2C P18825 1/20 0.34
TNF P01375 1/20 0.33
GRM4 Q14833 1/20 0.33
GRIN2D O15399 2/20 0.32
GRIN3B O60391 2/20 0.32
GRIN1 Q05586 2/20 0.32
GRIN2A Q12879 2/20 0.32
GRIN2B Q13224 2/20 0.32
GRIN2C Q14957 2/20 0.32
GRIN3A Q8TCU5 2/20 0.32
DRD2 P14416 1/20 0.32
DRD3 P35462 1/20 0.32
BCDIN3D Q7Z5W3 1/20 0.31
CNR1 P21554 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21507537 0.72 SMN1; SMN2 (0.35) SMN1; SMN2ALDH1A1BCDIN3DCNR1CNR2
SCHEMBL587580 0.71 DRD2 (0.36) SMN1; SMN2TNFGRM4DRD2DRD3
SCHEMBL16955156 0.66 ENPP2 (0.40) TNFGRM4GRIN2DGRIN3BGRIN1
SCHEMBL29013128 0.65 GRM4 (0.44) ADRA2CTNFGRM4BCDIN3DS1PR1
Ethylene SCHEMBL7173481 0.64 GRM4 (0.43) ALDH1A1TNFGRM4GRIN2DGRIN3B
SCHEMBL6163795 0.64 ENPP2 (0.46) ALDH1A1MAPTTNFGRM4GRIN2D
SCHEMBL2939744 0.63 GRM4 (0.44) ALDH1A1TNFGRM4GRIN2DGRIN3B
SCHEMBL3882898 0.63 GSK3B (0.50) ALDH1A1MAPTTNFGRM4DRD2
SCHEMBL4083138 0.63 ENPP2 (0.47) ALDH1A1MAPTTNFGRM4DRD2
SCHEMBL16951467 0.62 ENPP2 (0.39) TNFGRM4CNR1CNR2S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2348023-B9 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors INCYTE HOLDINGS CORP (US) 2017-03-08 EP disclosed